FindTrial
Sign In

Intervention program to reduce irrational antimicrobial prescriptions by the physicians in District Panchkula, Haryana

Effectiveness of a multi-pronged intervention program to reduce irrational antimicrobial prescriptions in District Panchkula, Haryana - EMIPRAP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039467
Enrollment
1040
Registered
2022-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A00-B99- Certain infectious and parasitic diseases Health Condition 2: K00-K95- Diseases of the digestive system Health Condition 3: H60-H95- Diseases of the ear and mastoid process Health Condition 4: N00-N99- Diseases of the genitourinary system Health Condition 5: J00-J99- Diseases of the respiratory system Health Condition 6: A30-A49- Other bacterial diseases Health Condition 7: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere cl

Interventions

Intervention1: Socio-ecological model by Bronfenbrenner: The intervention based on socio-ecological model will be given at four levels i.e. Individual, Interpersonal, Institutional, and Policy levels.

Sponsors

Dr Adarsh Bansal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria: • Doctors practicing allopathic medicine in study health facilities • Doctors providing written consent for participation in the study.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: • Doctors not practicing allopathic medicine in study health facilities • Doctors not willing to provide written consent

Design outcomes

Primary

MeasureTime frame
Change in percentage of appropriateness of antimicrobial prescription118 in terms of â?¢ unnecessary use, â?¢ choice of antimicrobials, â?¢ dosage and frequency of antimicrobials, â?¢ inappropriate instructions for follow up, â?¢ poly-pharmacy Timepoint: At Baseline At endline At 6 months post intervention—

Secondary

MeasureTime frame
Secondary Outcomes â?¢ Change in mean duration of disease. â?¢ Percentage change in treatment guideline adherence â?¢ Change in days of therapy (DOT) will be calculated for pediatric cohort Total duration of disease â?? total days for which antimicrobials were prescribed â?¢ Change in defined daily doses per person will be calculated for antimicrobial prescriptions for adult patients Defined daily doses (DDDs) Timepoint: At Baseline At endline At 6 months post intervention—

Countries

India

Contacts

Public ContactMadhu Gupta

POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH

madhugupta21@gmail.com07009769629

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026